Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-12-01T04:13:01.547Z Has data issue: false hasContentIssue false
  • English
  • Français

545 – Paranoid Schizophrenia in Kallmann Syndrome: Genetics and Psychopathology

Published online by Cambridge University Press:  15 April 2020

W. Verhoeven ,
J. Egger ,
T. Onderwater ,
J. Hovens ,
N. De Leeuw  and
L. Hoefsloot
W. Verhoeven
Affiliation:
Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray Department of Psychiatry, Erasmus University Medical Centre, Rotterdam
J. Egger
Affiliation:
Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray Donders Institute for Brain, Cognition and Behaviour Behavioural Science Institute, Radboud University Nijmegen, Nijmegen
T. Onderwater
Affiliation:
Department of Psychiatric Rehabilitation
J. Hovens
Affiliation:
Department of Clinical Research, Delta Psychiatric Hospital, Poortugaal Institute of Psychology, Erasmus University, Rotterdam
N. De Leeuw
Affiliation:
Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands
L. Hoefsloot
Affiliation:
Department of Human Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Kallmann syndrome (KS) is a genetically heterogenous and rare disorder characterized by the combination of hypothalamic hypogonadism and anosmia/hyposmia. In about one third of the patients, mutations have been identified in at least seven different genes. Apart from one published case report, virtually no data are available about possible neuropsychiatric symptoms in KS.

Objectives:

Studying the putative relationship between KS and schizophrenia.

Aims:

Investigating the genetic etiology in a patient with a clinical diagnosis of KS and paranoid schizophrenia.

Methods:

Detailed diagnostic evaluation including genetic analysis of an adult male patient with paranoid schizophrenia, hypogonadism and anosmia.

Results:

Psychiatric examination of the 28-years-old male patient disclosed negative psychotic symptoms only, following an acute paranoid schizophrenic episode one year before. He used 15mg aripiprazole daily and testosterone gel 20mg/gr. Hormonal panel showed extremely low levels of LH and FSH. MRI scanning of the brain demonstrated complete absence of the olfactory bulbs. Otolaryngeal examination disclosed complete anosmia. Neuropsychological assessment revealed subaverage intelligence distinctly disconcordant with premorbid functioning, markedly lowered speed of information processing, and impaired executive and social cognitive functions. Genome wide SNP array analysis and mutation analyses for the KAL1, FGFR1, PROK2, PROKR2, FGF8 and CHD7 genes, disclosed no genetic imbalance or any pathogenic mutation.

Conclusions:

This first report on a patient with KS and paranoid schizophrenia in whom extensive genetic analyses were performed, stipulates the need for studying a possible increased risk for psychiatric symptoms in patients with KS.

Type
Abstract
Information
European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E126
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.